Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SNORA29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ERI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GXYLT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDH18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AASDHPPT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXA-AS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC100129034 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PWP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DONSON - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF831 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP11A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZAK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POLE2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DEPDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MINOS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ASUN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMC3IP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDCA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on